Viral cirrhosis after liver transplantation C

This liver transplant only gets lower than those obtained after viral cirrhosis B results (65% survival after 5 years instead of 85%).
This is consistent with the constant recurrence after transplant viral C.
Nevertheless, the anti-viral treatment, consisting of ribavirin and pegylated interferon administered on the graft at a stage of non-advanced fibrosis, increases the chances of recovery.
New antiviral treatments C will soon boulverver indications of transplantation and to improve survival after transplantation.? Indeed it is possible to highlight a better control of viral load before liver transplantation.